Antimicrobial agents and chemotherapy

• 

  Año 2003, Vol. 47, Número 12

  • Ribosomal Protection Proteins and Their Mechanism of Tetracycline Resistance

    Sean R. Connell

    págs. 3675-3681

    

  • Improved Green Fluorescent Protein Reporter Gene-Based Microplate Screening for Antituberculosis Compounds by Utilizing an Acetamidase Promoter

    P. Palittapongarnpim, S. G. Franzblau, C. Changsen

    págs. 3682-3687

    

  • Treatment of Intra-Abdominal Abscesses Caused by Candida albicans with Antifungal Agents and Recombinant Murine Granulocyte Colony-Stimulating Factor

    M. G. Netea, J. H. van Krieken, A. G. Vonk

    págs. 3688-3693

    

  • Effects of DQ-113, a New Quinolone, against Methicillin-and Vancomycin-Resistant Staphylococcus aureus-Caused Hematogenous Pulmonary Infections in Mice

    K. Yanagihara, Y. Kaneko

    págs. 3694-3698

    

  • In Vivo Efficacy of a New Quinolone, DQ-113, against Streptococcus pneumoniae in a Mouse Model

    K. Yanagihara, Y. Otsu

    págs. 3699-3703

    

  • Effect of Moxifloxacin on Production of Proinflammatory Cytokines from Human Peripheral Blood Mononuclear Cells

    J.H. Choi, M.J. Song

    págs. 3704-3707

    

  • Antimalarial 9-Anilinoacridine Compounds Directed at Hematin

    S. Auparakkitanon

    págs. 3708-3712

    

  • In Vitro Evaluation of a New Treatment for Urinary Tract Infections Caused by Nitrate-Reducing Bacteria

    S. Carlsson

    págs. 3713-3718

    

  • Epidemiology of Nalidixic Acid Resistance and TEM-1- and TEM-52-Mediated Ampicillin Resistance of Shigella sonnei Isolates Obtained in Korea between 1980 and 2000

    Y. S. Jeong

    págs. 3719-3723

    

  • Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals

    M. Edelstein

    págs. 3724-3732

    

  • EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis

    M. N. Huda, E. W. Lee

    págs. 3733-3738

    

  • In Vivo Selection of a Chromosomally Encoded beta-Lactamase Variant Conferring Ceftazidime Resistance in Klebsiella oxytoca

    H. Mammeri, L. Poirel, P. Nordmann

    págs. 3739-3742

    

  • Fusidic Acid-Resistant Mutants of Salmonella enterica Serovar Typhimurium with Low Fitness In Vivo Are Defective in RpoS Induction

    M. Macvanin, J. Bjorkman, S. Eriksson

    págs. 3743-3749

    

  • In Vitro and In Vivo Antibacterial Activities of DK-507k, a Novel Fluoroquinolone

    M. Tanaka, T. Otani

    págs. 3750-3759

    

  • In Vitro Activity of Daptomycin against Vancomycin-Resistant Enterococci of Various Van Types and Comparison of Susceptibility Testing Methods

    S. A. Crawford, J. H. Jorgensen

    págs. 3760-3763

    

  • Increased Killing of Staphylococci and Streptococci by Daptomycin Compared with Cefazolin and Vancomycin in an In Vitro Peritoneal Dialysate Model

    E. D. Hermsen

    págs. 3764-3767

    

  • Efficacies of Vancomycin, Arbekacin, and Gentamicin Alone or in Combination against Methicillin-Resistant Staphylococcus aureus in an In Vitro Infective Endocarditis Model

    H.S. Chun, D. G. Lee

    págs. 3768-3773

    

  • Toxicity and Antileishmanial Activity of a New Stable Lipid Suspension of Amphotericin B

    M. Larabi, P. M. Loiseau, V. Yardley

    págs. 3774-3779

    

  • Nitazoxanide in Treatment of Helicobacter pylori: a Clinical and In Vitro Study

    H. M. Windsor, Y. Guttner

    págs. 3780-3783

    

  • Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes

    L. R. Stanberry, D. I. Bernstein

    págs. 3784-3788

    

  • Concentrations in Plasma, Urinary Excretion, and Bactericidal Activity of Linezolid (600 Milligrams) versus Those of Ciprofloxacin (500 Milligrams) in Healthy Volunteers Receiving a Single Oral Dose

    F. M. E. Wagenlehner

    págs. 3789-3794

    

  • Artemether Bioavailability after Oral or Intramuscular Administration in Uncomplicated Falciparum Malaria

    P. Teja Isavadharm, K. Silamut, P. N. Newton

    págs. 3795-3798

    

  • ethA, inhA, and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates

    G. P. Morlock

    págs. 3799-3805

    

  • 5HT1A Serotonin Receptor Agonists Inhibit Plasmodium falciparum by Blocking a Membrane Channel

    P. C. Ruben, C. P. Locher

    págs. 3806-3809

    

  • Antimalarial Activities of Novel Synthetic Cysteine Protease Inhibitors

    M. I. Weinhouse, A. Singh, E. A. Goldman, S. J. Kemp, B. J. Lee, P. Chiang

    págs. 3810-3814

    

  • Antipneumococcal Activity of DK-507k, a New Quinolone, Compared with the Activities of 10 Other Agents

    F. A. Browne, B. Bozdogan

    págs. 3815-3824

    

  • Antimicrobial Resistance in Campylobacter jejuni and Campylobacter coli Strains Isolated in 1991 and 2001-2002 from Poultry and Humans in Berlin, Germany

    P. Luber, J. Wagner

    págs. 3825-3830

    

  • Novel Antibacterial Class

    P. J. Dandliker

    págs. 3831-3839

    

  • GeneHunter, a Transposon Tool for Identification and Isolation of Cryptic Antibiotic Resistance Genes

    S. J. Salipante

    págs. 3840-3845

    

  • Randomized, Single-Blind, Placebo-Controlled Study of Topical Application of the Immune Response Modulator Resiquimod in Healthy Adults

    M. H. Smith, D. N. Sauder, T. Senta McMillian

    págs. 3846-3852